Summit Therapeutics (SMMT) Fails to deliver data

Key failure to deliver metrics for Summit Therapeutics :

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: A$5.4 M
• Last 3 months FTD volume: A$0.11 B
• Last 12 months FTD volume: A$0.32 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Summit Therapeutics (SMMT) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Summit Therapeutics (SMMT) - since 2020

Summit Therapeutics (SMMT) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Sarepta Therapeutics SRPT	A$2.3 M	A$22.38 M	🇺🇸 USA
Arena Pharmaceuticals ARNA	N/A	A$0.21 B	🇺🇸 USA
Merrimack Pharmaceuticals MACK	N/A	A$4.65 M	🇺🇸 USA
Coherus BioSciences CHRS	A$1.31 M	A$5.41 M	🇺🇸 USA